ng-nitroarginine methyl ester has been researched along with Precancerous Conditions in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamori, T; Nakatsugi, S; Ohta, T; Sugimura, T; Takahashi, M; Wakabayashi, K; Watanabe, K | 1 |
| Bergmann, C; Duranton, B; Gossé, F; Raul, F; Schleiffer, R | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Precancerous Conditions
| Article | Year |
|---|---|
Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor.
Topics: Animals; Anticarcinogenic Agents; Antigens, Nuclear; Azoxymethane; Body Weight; Carcinogens; Cell Division; Cell Nucleus; Colon; Colonic Neoplasms; Intestinal Mucosa; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nuclear Proteins; Precancerous Conditions; Rats; Rats, Inbred F344 | 2000 |
Nitric oxide synthase inhibition promotes carcinogen-induced preneoplastic changes in the colon of rats.
Topics: Adenosylmethionine Decarboxylase; Animals; Azoxymethane; Biogenic Polyamines; Blood Pressure; Body Weight; Carcinogens; Colon; Cyclic GMP; Enzyme Inhibitors; Heart Rate; Intestinal Mucosa; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ornithine Decarboxylase; Precancerous Conditions; Putrescine; Rats; Rats, Wistar; Spermidine; Spermine | 2000 |